Cargando…

Associations between essential medicines and health outcomes for cardiovascular disease

BACKGROUND: National essential medicines lists are used to guide medicine reimbursement and public sector medicine procurement for many countries therefore medicine listings may impact health outcomes. METHODS: Countries’ national essential medicines lists were scored on whether they listed proven m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steiner, Liane, Fraser, Shawn, Maraj, Darshanand, Persaud, Nav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992928/ https://www.ncbi.nlm.nih.gov/pubmed/33765933 http://dx.doi.org/10.1186/s12872-021-01955-1

Ejemplares similares

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
por: Maraj, Darshanand, et al.
Publicado: (2022)

A comparison of national essential medicines lists in the Americas
por: Steiner, Liane, et al.
Publicado: (2020)

Exploring the experiences of people in Ontario, Canada who have trouble affording medicines: a qualitative concept mapping study
por: Yaphe, Hannah, et al.
Publicado: (2019)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Biologic medicine inclusion in 138 national essential medicines lists
por: Kraus, Raphaël, et al.
Publicado: (2021)

Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
por: Ally, Muhamad Z., et al.
Publicado: (2020)

Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study
por: Taglione, Michael Sergio, et al.
Publicado: (2021)

Health outcomes related to the provision of free, tangible goods: A systematic review
por: Persaud, Nav, et al.
Publicado: (2019)

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
por: Richards, Georgia C, et al.
Publicado: (2020)

Withdrawn medicines included in the essential medicines lists of 136 countries
por: Charles, Onella, et al.
Publicado: (2019)

Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing
por: Spithoff, Sheryl, et al.
Publicado: (2020)

Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Effect of free medicine distribution on ability to make ends meet: post hoc quantitative subgroup analysis and qualitative thematic analysis
por: Hess, Margaret, et al.
Publicado: (2022)

How Can Journals Respond to Threats of Libel Litigation?
por: Persaud, Nav, et al.
Publicado: (2014)

Does exposure to simulated patient cases improve accuracy of clinicians’ predictive value estimates of diagnostic test results? A within-subjects experiment at St Michael’s Hospital, Toronto, Canada
por: Armstrong, Bonnie, et al.
Publicado: (2018)

Dr Alexander Augusta sought medical education in Canada but became a medical educator in America after the Civil War
por: Persaud, Nav, et al.
Publicado: (2021)

Search for unpublished data by systematic reviewers: an audit
por: Ziai, Hedyeh, et al.
Publicado: (2017)

Effect of free distribution of medicines on the process of care for adult patients with type 1 and type 2 diabetes and hypertension: post hoc analysis of randomised controlled trial findings
por: Charles, Onella, et al.
Publicado: (2021)

Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial
por: Persaud, Nav, et al.
Publicado: (2021)

Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal
por: Gama, Helena, et al.
Publicado: (2017)

Access to Essential Medicines and Diagnostic Tests for Cardiovascular Diseases in Maputo City, Mozambique
por: Jessen, Neusa, et al.
Publicado: (2023)

Using a systematic review in clinical decision making: a pilot parallel, randomized controlled trial
por: Perrier, Laure, et al.
Publicado: (2015)

Gender and racialisation of pharmaceutical sector leaders in Canada: a cross-sectional study
por: Satgunanathan, Kasthuri, et al.
Publicado: (2023)

The commercialization of patient data in Canada: ethics, privacy and policy
por: Spithoff, Sheryl, et al.
Publicado: (2022)

Commercialisation des données sur les patients au Canada: éthique, protection des renseignements personnels et politiques
por: Spithoff, Sheryl, et al.
Publicado: (2022)

Association of Cardiovascular Health Assessed by the New Life's Essential 8 Metrics With Years Lived Without Cardiovascular Disease
por: Xia, Xue, et al.
Publicado: (2023)

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
por: Bazargani, Y. T., et al.
Publicado: (2018)

Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
por: Husain, Muhammad Jami, et al.
Publicado: (2020)

Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial
por: Persaud, Nav, et al.
Publicado: (2017)

Factors associated with the availability and affordability of essential cardiovascular disease medicines in low- and middle-income countries: A systematic review
por: Lotfizadeh, Ali, et al.
Publicado: (2022)

Essential Medicinal Chemistry of Essential Medicines
por: Serafini, Marta, et al.
Publicado: (2020)

Correction to: Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability
Publicado: (2020)

Noncommunicable diseases, access to essential medicines and universal health coverage
por: Beran, David, et al.
Publicado: (2019)

Predictive Value of Cardiovascular Health Score for Health Outcomes in Patients with PCI: Comparison between Life’s Simple 7 and Life’s Essential 8
por: Gao, Xueqin, et al.
Publicado: (2023)

Identifying top 10 primary care research priorities from international stakeholders using a modified Delphi method
por: O’Neill, Braden, et al.
Publicado: (2018)

Essential medicines for universal health coverage
por: Wirtz, Veronika J, et al.
Publicado: (2017)

WHO essential medicines for reproductive health
por: Gill, Roopan, et al.
Publicado: (2019)

A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
por: Naicker, Ian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n3lavf1gsovhuk7n9dr2os9f7o